p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells-Reference-Cited by-同舟云学术

p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells

Published:2012-10 Issue:5 Volume:14 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Bisaro Brigitte,Montani Maura,Konstantinidou Georgia,Marchini Cristina,Pietrella Lucia,Iezzi Manuela,Galiè Mirco,Orso Francesca,Camporeale Annalisa,Colombo Shana M,Di Stefano Paola,Tornillo Giusy,Camacho-Leal Maria P,Turco Emilia,Taverna Daniela,Cabodi Sara,Amici Augusto,Defilippi Paola

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3342.pdf

Reference44 articles.

1. Defilippi P, Di Stefano P, Cabodi S: p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 2006, 16: 257-263.

2. Tikhmyanova N, Little JL, Golemis EA: CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci. 2009, 67: 1025-1048.

3. Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P: Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer. 2010, 10: 858-870.

4. Sawada Y, Tamada M, Dubin-Thaler BJ, Cherniavskaya O, Sakai R, Tanaka S, Sheetz MP: Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell. 2006, 127: 1015-1026.

5. Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T, Saito T, Nakamura K, Nakao K, Ishikawa T, Katsuki M, Yazaki Y, Hirai H: Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet. 1998, 19: 361-365.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A p130Cas-Mediated Mechanism Governs Acinar to Ductal Metaplasia and the Initiation of Pancreatic Ductal Adenocarcinoma;Gastroenterology;2022-04

2. p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?;Frontiers in Cell and Developmental Biology;2021-10-11

3. Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells;Frontiers in Chemistry;2021-01-11

4. Evaluation of anticancer role of a novel ruthenium(II)-based compound compared with NAMI-A and cisplatin in impairing mitochondrial functionality and promoting oxidative stress in triple negative breast cancer models;Mitochondrion;2021-01

5. Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice;Pharmacological Research;2020-11